99.22
price up icon0.32%   0.32
after-market Handel nachbörslich: 99.63 0.41 +0.41%
loading
Schlusskurs vom Vortag:
$98.90
Offen:
$98.36
24-Stunden-Volumen:
5.25M
Relative Volume:
0.85
Marktkapitalisierung:
$146.43B
Einnahmen:
$16.75B
Nettoeinkommen (Verlust:
$1.85B
KGV:
79.38
EPS:
1.25
Netto-Cashflow:
$2.37B
1W Leistung:
+3.87%
1M Leistung:
-5.82%
6M Leistung:
+20.16%
1J Leistung:
+47.56%
1-Tages-Spanne:
Value
$97.93
$99.41
1-Wochen-Bereich:
Value
$94.85
$99.41
52-Wochen-Spanne:
Value
$66.80
$107.17

Boston Scientific Corp Stock (BSX) Company Profile

Name
Firmenname
Boston Scientific Corp
Name
Telefon
508-683-4000
Name
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
Mitarbeiter
53,000
Name
Twitter
@bostonsci
Name
Nächster Verdiensttermin
2024-10-23
Name
Neueste SEC-Einreichungen
Name
BSX's Discussions on Twitter

Vergleichen Sie BSX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
BSX
Boston Scientific Corp
99.22 146.43B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
ABT
Abbott Laboratories
126.30 219.05B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
SYK
Stryker Corp
375.91 143.44B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
92.21 118.24B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.34 41.35B 5.72B 4.17B 259.90M 6.97

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-01-10 Hochstufung Deutsche Bank Hold → Buy
2024-10-18 Herabstufung Needham Buy → Hold
2024-05-30 Eingeleitet Goldman Buy
2024-02-01 Hochstufung Mizuho Neutral → Buy
2023-07-19 Eingeleitet Robert W. Baird Outperform
2023-06-30 Eingeleitet CL King Buy
2023-05-30 Fortgesetzt Morgan Stanley Overweight
2023-03-29 Eingeleitet UBS Buy
2022-12-22 Eingeleitet Mizuho Neutral
2022-12-20 Fortgesetzt Citigroup Buy
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Buy
2022-07-06 Eingeleitet Wolfe Research Outperform
2022-05-27 Hochstufung Needham Hold → Buy
2022-04-13 Fortgesetzt Truist Buy
2022-03-02 Fortgesetzt BofA Securities Buy
2021-12-10 Eingeleitet RBC Capital Mkts Outperform
2021-05-26 Herabstufung Needham Buy → Hold
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Overweight
2020-09-17 Eingeleitet Truist Buy
2020-09-11 Eingeleitet Wolfe Research Peer Perform
2020-04-22 Herabstufung SVB Leerink Outperform → Mkt Perform
2020-04-01 Hochstufung Goldman Neutral → Buy
2020-03-05 Eingeleitet Citigroup Buy
2020-02-13 Eingeleitet Goldman Neutral
2020-02-06 Fortgesetzt BTIG Research Buy
2019-12-30 Bestätigt Cowen Outperform
2019-12-19 Herabstufung Needham Strong Buy → Buy
2019-09-05 Fortgesetzt JP Morgan Overweight
2019-09-03 Fortgesetzt Barclays Overweight
2019-05-13 Hochstufung Evercore ISI In-line → Outperform
2018-11-28 Eingeleitet UBS Buy
2018-10-16 Eingeleitet Barclays Overweight
2018-10-02 Bestätigt Morgan Stanley Overweight
2018-09-07 Bestätigt Needham Strong Buy
2018-09-04 Hochstufung Jefferies Hold → Buy
2018-07-06 Bestätigt Needham Strong Buy
2018-06-27 Eingeleitet Bernstein Outperform
2018-04-26 Bestätigt Needham Strong Buy
Alle ansehen

Boston Scientific Corp Aktie (BSX) Neueste Nachrichten

pulisher
Mar 17, 2025

Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance

Mar 17, 2025
pulisher
Mar 17, 2025

Neurotech Devices Market Is Booming Worldwide 2025-2032 | - openPR

Mar 17, 2025
pulisher
Mar 13, 2025

Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth By Investing.com - Investing.com South Africa

Mar 13, 2025
pulisher
Mar 13, 2025

Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com

Mar 13, 2025
pulisher
Mar 12, 2025

Neurosurgery Market Size to Reach USD 6.8 Billion by 2034, Growing at 4.5% CAGR with Technological Advancements and Rising Focus on Personalized Medicine – Analysis by TMR - GlobeNewswire Inc.

Mar 12, 2025
pulisher
Mar 11, 2025

Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

Boston Scientific (NYSE:BSX) Sees 4% Price Rise Following Strong Earnings Report - Yahoo Finance

Mar 11, 2025
pulisher
Mar 11, 2025

Boston Scientific Gains 42.2% in a Year: What's Driving the Stock? - Yahoo Finance

Mar 11, 2025
pulisher
Mar 08, 2025

Boston Scientific price target raised to $110 from $100 at Bernstein - MSN

Mar 08, 2025
pulisher
Mar 08, 2025

Estimating The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Finance

Mar 08, 2025
pulisher
Mar 06, 2025

4C raises $175M for mitral valve technology - BioWorld Online

Mar 06, 2025
pulisher
Mar 06, 2025

Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Mar 06, 2025
pulisher
Mar 06, 2025

How Boston Scientific (sort of) became ‘Minnesota Scientific’ - Star Tribune

Mar 06, 2025
pulisher
Mar 06, 2025

Boston Scientific at TD Cowen Conference: Strategic Growth Insights - Investing.com

Mar 06, 2025
pulisher
Mar 05, 2025

Boston Scientific (BSX) Gains But Lags Market: What You Should Know - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

Ajax, Boston Sci partner to develop new heart failure treatment - BioWorld Online

Mar 05, 2025
pulisher
Mar 05, 2025

Boston Scientific Stock: Is BSX Outperforming the Healthcare Sector? - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

Insider Sell: Jeffrey Mirviss Sells 13,022 Shares of Boston Scie - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views? - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

Boston Scientific Stock: Is BSX Outperforming The Healthcare Sector? - Barchart

Mar 05, 2025
pulisher
Mar 04, 2025

Five things you need to know, and going for a chilly swim - The Business Journals

Mar 04, 2025
pulisher
Mar 04, 2025

Boston Scientific buys Tivus system developer SoniVie in $540m deal - Medical Device Network

Mar 04, 2025
pulisher
Mar 03, 2025

Boston Scientific Buying $600M Ultrasound System Developer - Law360

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific to acquire Sonivie for up to $600M - BioWorld Online

Mar 03, 2025
pulisher
Mar 03, 2025

Beyond The Numbers: 17 Analysts Discuss Boston Scientific Stock - Benzinga

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific makes second acquisition for $360M upfront - The Business Journals

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific to Purchase SoniVie Ltd. - MPO-mag

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific to acquire renal denervation company SoniVie - Mass Device

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific Announces Agreement To Acquire Sonivie Ltd -March 03, 2025 at 08:55 am EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific to acquire remaining 90% stake of SoniVie for $360M - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific To Buy SoniVie For Upfront Payment Of Approx. $360 Mln - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Boston Scientific announces agreement to acquire SoniVie Ltd. - Quantisnow

Mar 03, 2025
pulisher
Mar 03, 2025

The Zacks Analyst Blog The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard - Zacks Investment Research

Mar 03, 2025
pulisher
Mar 02, 2025

Boston Scientific Corporation entered into a definitive agreement to acquire remaining 90% stake in SoniVie Ltd for $540 million. - Marketscreener.com

Mar 02, 2025
pulisher
Mar 01, 2025

Cavalier Investments LLC Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Bank of New York Mellon Corp Has $1.11 Billion Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Top Stock Reports for Goldman Sachs, Progressive & Boston Scientific - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

Boston Scientific Stock Price | BSX Stock Quote, News, and History - Markets Insider

Feb 28, 2025
pulisher
Feb 28, 2025

Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 4,675 Shares of Stock - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

Consilium Wealth Advisory LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

April 11th Options Now Available For Boston Scientific (BSX) - Nasdaq

Feb 27, 2025
pulisher
Feb 27, 2025

Boston Scientific Corporation (BSX): Among Stocks to Invest In from Israel Englander’s Portfolio - Insider Monkey

Feb 27, 2025
pulisher
Feb 27, 2025

Boston Scientific Co. (NYSE:BSX) Shares Acquired by Alecta Tjanstepension Omsesidigt - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

New York Life Investment Management LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Fisher Funds Management LTD Buys New Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat

Feb 27, 2025
pulisher
Feb 26, 2025

Boston Scientific Announces Completion Of EUR1.5 Billion Offering Of Senior Notes - Marketscreener.com

Feb 26, 2025
pulisher
Feb 26, 2025

Boston Scientific announces completion of €1.5 billion offering of senior notes - Quantisnow

Feb 26, 2025
pulisher
Feb 26, 2025

Catheter Market Global Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, BD and Co, Boston Scientific, Teleflex, Medtronic, Johnson & Johnson, Edwards Lifesciences, Stryker - Yahoo Finance

Feb 26, 2025
pulisher
Feb 26, 2025

Boston Scientific's SWOT analysis: innovative medtech stock poised for growth - Investing.com

Feb 26, 2025
pulisher
Feb 25, 2025

$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today - Benzinga

Feb 25, 2025
pulisher
Feb 25, 2025

Boston Scientific Recalls Accolade Pacemaker Devices - The Rochester Sentinel

Feb 25, 2025

Finanzdaten der Boston Scientific Corp-Aktie (BSX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices SYK
$375.91
price up icon 0.65%
medical_devices MDT
$92.21
price down icon 1.22%
medical_devices ABT
$126.30
price down icon 1.05%
medical_devices EW
$70.34
price down icon 0.41%
$82.14
price down icon 0.40%
Kapitalisierung:     |  Volumen (24h):